Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat

Current understanding of human immunodeficiency virus type 1 (HIV-1) transcription is based on unidirectional expression of transcripts with positive-strand polarity from the 5' long terminal repeat. We now report HIV-1 transcripts with negative-strand polarity obtained from acutely and chronically infected cell lines by use of a template orientation-specific reverse transcriptase-PCR assay. These findings were confirmed in natural infection by analysis of RNA derived from peripheral blood mononuclear cell samples from 15 HIV-1-infected patients. A cDNA derived from a 2.3-kb polyadenylated HIV-1 RNA with negative-strand polarity which encodes a highly conserved 189-amino-acid open reading frame antiparallel to the envelope gene was isolated from acutely infected A3.01 cells. Through use of reporter gene constructions, we further found that a novel negative-strand promoter functions within the negative response element of the 3' long terminal repeat, which is downregulated by coexpression of Tat. Site-directed mutagenesis experiments demonstrated that NF-kappa B I and USF sites are crucial for negative-strand promoter activity. These data extend the coding capacity of HIV-1 and suggest a role for antisense regulation of the viral life cycle.

[1]  R. Redfield,et al.  Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease , 1992, Journal of virology.

[2]  M. Vahey Viral DNA andmRNA Expression Correlate withtheStage of HumanImmunodeficiency Virus(HIV)Type1Infection inHumans: Evidence forViral Replication inAllStages ofHIVDisease , 1992 .

[3]  M. Giacca,et al.  A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. , 1992, Virology.

[4]  B. Cullen,et al.  Regulation of HIV‐1 gene expression , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  D. Baltimore,et al.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Sodroski,et al.  Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1 , 1990, Journal of virology.

[7]  J. Zack,et al.  Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[8]  D. Richman,et al.  Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells , 1990, Journal of virology.

[9]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[10]  M. Bukrinsky,et al.  Plus strand of the HIV provirus DNA is expressed at early stages of infection. , 1990, AIDS research and human retroviruses.

[11]  M. Mathews,et al.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation , 1989, Cell.

[12]  K. Khalili,et al.  The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. , 1989, The New biologist.

[13]  M. Seto,et al.  Human T-cell leukemia virus minus strand transcription in infected T-cells. , 1989, Biochemical and biophysical research communications.

[14]  J. Sodroski,et al.  Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication , 1989, Journal of virology.

[15]  B. Cullen,et al.  Regulatory pathways governing HIV-1 replication , 1989, Cell.

[16]  D. Baltimore,et al.  The “initiator” as a transcription control element , 1989, Cell.

[17]  P. Luciw,et al.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. , 1989, Genes & development.

[18]  E. Wagner,et al.  Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. , 1988, The Journal of infectious diseases.

[19]  R. Miller,et al.  Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand. , 1988, Science.

[20]  J. Justement,et al.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. , 1988, Journal of immunology.

[21]  H. Varmus,et al.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.

[22]  P. Luciw,et al.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product , 1987, Nature.

[23]  J. N. Topper,et al.  Promoter selection in human mitochondria involves binding of a transcription factor to orientation-independent upstream regulatory elements , 1987, Cell.

[24]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.

[25]  D. Capon,et al.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.

[26]  E. Wagner,et al.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. , 1987, Science.

[27]  M. Feinberg,et al.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA , 1986, Cell.

[28]  D. A. Clayton,et al.  Precise assignment of the light-strand promoter of mouse mitochondrial DNA: a functional promoter consists of multiple upstream domains , 1986, Molecular and cellular biology.

[29]  D. A. Clayton,et al.  Precise assignment of the heavy-strand promoter of mouse mitochondrial DNA: cognate start sites are not required for transcriptional initiation , 1986, Molecular and cellular biology.

[30]  J. Sodroski,et al.  Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. , 1985, Science.

[31]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[32]  J. Sodroski,et al.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.

[33]  L. Lasky,et al.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus , 1985, Nature.

[34]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[35]  G. Schoolnik,et al.  All eight unassigned reading frames of mouse mitochondrial DNA are expressed. , 1984, The EMBO journal.

[36]  G. Shaw,et al.  Molecular cloning and characterization of the HTLV-III virus associated with AIDS , 1984, Nature.

[37]  J. Nevins The pathway of eukaryotic mRNA formation. , 1983, Annual review of biochemistry.

[38]  D. A. Clayton,et al.  Sequence and gene organization of mouse mitochondrial DNA , 1981, Cell.

[39]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.